Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

CherryAde sports drink

This article was originally published in The Tan Sheet

  • News

Executive Summary

Geneva, N.Y.-based CherryPharm consumer health product firm announces the August launch of its eponymous all-natural cherry juice which offers "proven natural recovery from muscle damage and pain experienced after strenuous activity or exercise," the firm states Aug. 28. Each 8 oz serving of CherryPharm contains approximately 50 cherries and is available for sale on the firm's website for $2 per bottle...

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

US FDA Inspectors, Product Centers Working Closer Together Ahead Of ORA Reorg

Not-For-Profit Models Needed For Commercially Unviable Rare Disease Drugs

EU Urban Wastewater Directive Update ‘Unfairly Targets Pharmaceutical Industry’

Swissmedic Gets New Grant For Regulatory Strengthening In LMICs

See All
UsernamePublicRestriction

Register

PS099717

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By